LIVZON PHARMAC. GRP H YC1 (LP6) — Financial Flexibility Index
LIVZON PHARMAC. GRP H YC1 (LP6) has a Financial Flexibility Index of 0.44x as of December 2025. Free cash flow of €3.72 Billion (operating CF €3.15 Billion minus capex €574.14 Million) represents 0% of total liabilities (€8.44 Billion). Also explore LIVZON PHARMAC. GRP H YC1 (LP6) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LIVZON PHARMAC. GRP H YC1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LIVZON PHARMAC. GRP H YC1 across 5 annual periods. Check LP6 financial resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for LIVZON PHARMAC. GRP H YC1 (2021–2025)
Year-by-year free cash flow to debt coverage for LIVZON PHARMAC. GRP H YC1. For the full company profile including market capitalisation, see LIVZON PHARMAC. GRP H YC1 (LP6) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €3.72 Billion | €3.15 Billion | €8.44 Billion | ▲ +18.6% |
| 2024 | 0.37x | €3.55 Billion | €2.98 Billion | €9.55 Billion | ▼ -6.1% |
| 2023 | 0.40x | €4.07 Billion | €3.25 Billion | €10.28 Billion | ▲ +5.9% |
| 2022 | 0.37x | €3.71 Billion | €2.77 Billion | €9.93 Billion | ▼ -6.2% |
| 2021 | 0.40x | €3.21 Billion | €1.90 Billion | €8.06 Billion | — |